Harvard Business Review
Over the past century, almost all the compelling examples of philanthropic impact involve multiple grant makers, nonprofits and other organizations working together toward common goals. Think of the campaign against tuberculosis a century ago involving foundations, nonprofits and insurance companies. Or think of the work by so many on gay rights in recent decades.
Big progress against tough challenges requires a lot of effective organizations working together.
Fundraisers need to understand better how people (i.e., donors) process the "stuff" we throw at them — words, images, and experiences. Think about your very first contact with a donor. It must have been sufficiently satisfying to get "tagged" positively. Then, what did you do next to reinforce (or not) that initial tag? When your donors simply sees that logo of yours in their mailboxes, do they faint into your arms? I’d suggest your nonprofit gets two, maybe three, chances to ensure a strong positive tag.
For a resource-strapped nonprofit, taking on data analytics can seem like a monumental challenge. With the field of data analytics booming and salaries skyrocketing, attracting top-tier talent can take massive financial resources from organizations that may already be forced to make sacrifices just to operate. Second, without prior experience, it can be difficult to know what, if any, insights data can generate that would empower your organization to better achieve its mission. Here are some tips on how your organization can learn — and grow — from data.
Check out recent blog posts from the Harvard Business Review and Huffington Post.
Check out recent blog posts from The Harvard Business Review and Beth Kanter.
Eli Lilly and Co. announced a $30 million commitment over five years to fight the rising burden of non-communicable diseases in developing nations. Lilly is launching The Lilly NCD Partnership, which combines the company's unique resources with the expertise of leading global health organizations, to identify new models of patient care that increase treatment access and improve outcomes for underserved people. The partnership will initially focus on diabetes — a core business area in which Lilly has deep expertise.